Dr. Peter Rinck, PhD[email protected]ConferenceGetting ready for ECR ...It's almost time again for ECR and the customary niceties and the intense chatter and babble, as we all dive into the social dynamics of the conference and face the constant barrage of questions, the Maverinck writes. He takes a lighter look at what might lie ahead for you in Vienna.February 24, 2019Imaging InformaticsTo be seen or not seen, that is the question for radiologyOnce viewed as an "ancillary" service, radiology and its status and profile have risen steadily over the years, but more direct contact with patients now is essential if the profession is to rise to the next level, the Maverinck writes.January 24, 2019Artificial IntelligenceWhat will AI really mean for radiology?The concept behind artificial intelligence (AI) is seductive, and it will be a cash cow for developers and the industry, but the technology is immature, and it will never be a final product because the programs will need constant upgrades and updates, the Maverinck writes in his latest column.November 20, 2018Artificial IntelligenceWhy radiology must take care when it comes to AIArtificial intelligence (AI) is mindless, and this is a fundamental flaw, writes the Maverinck. There is no objectivity or neutrality in AI, and it's not a real science; it's closer to online gambling and tinkering than creating a fundamentally reliable support system for highly specific tasks, he argues.September 25, 2018MRIThe dilution and demise of human expertiseThe academic mindset has turned into fast McDonalds-style science, and hard evidence and clear and proven results are ousted by assertions lacking scientific foundations, the Maverinck writes. He fears the ivory tower of yore has been replaced by blathering smartphone science.July 3, 2018Clinical NewsGerman newspapers and the gadolinium controversyNot everything printed is true, but it may provide food for thought. This adage is particularly relevant when it comes to media coverage of the ongoing debate over the safety of gadolinium-based contrast agents, writes the Maverinck in his latest column.April 17, 2018Clinical NewsSome side effects of the great gadolinium scareThe news about gadolinium is having side effects -- many radiologists now are too scared to use any gadolinium-based contrast agent. But have the effects been overstated and overblown? The Maverinck investigates in his latest column.February 13, 2018Clinical NewsRelaxation times in MRI: Trying to map the biological worldRelaxation time measurements are back in fashion among the MRI community. Obsolete methods are being dug out again, and research funds are being spent on answering questions that were discarded years ago, writes the Maverinck in his hard-hitting new column.January 28, 2018Clinical NewsA short and critical approach to contrast agent safetyIn the current climate of "gadolinium phobia," it's difficult to know which contrast agent to use in a given clinical scenario and in what quantity. The Maverinck aims to bring some clarity and common sense to the ongoing safety debate in his latest column.September 7, 2017Clinical NewsWhen radiologists can be useful ...A little boy has a persistent cough, and the chest specialist suspects lung cancer. Then a retired radiologist intervenes and helps resolve the potential crisis. The Maverinck tells this simple tale.August 6, 2017Previous PagePage 3 of 10Next PageTop StoriesEmergency RadiologyJAMA: Radiology among least affected services in Ukraine warThe war in Ukraine has devastated healthcare services, but imaging and radiology facilities appear to be among the least affected, a large study has found.Enterprise ImagingAgfa secures agreement with Dublin hospitalCTUse CCTA to track vasculopathy risk in heart transplant patientsNuclear MedicineVienna-based EANM highlights record abstracts for Hamburg congressSponsor ContentJourney to the Cloud: A Snapshot of Market Progress - 22 May @ 7pm CET